STAT
OCTOBER 8, 2024
WASHINGTON — On Tuesday, Vice President Harris’ presidential campaign released a proposal to crack down on middlemen in the pharmaceutical industry. It seems billionaire business mogul Mark Cuban had a heads up.
PharmaVoice
OCTOBER 8, 2024
This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 8, 2024
On June 17, He Jiankui received an email that wasted no time getting to the point: An American cryptocurrency entrepreneur had learned about the Chinese scientist’s recent proposal to use CRISPR gene-editing technology on human embryos to lower their future risk of developing Alzheimer’s disease, and he was offering funding and other help to turn those plans into a new commercial venture. He rose to international infamy in 2018, when it came to light that he
pharmaphorum
OCTOBER 8, 2024
Discover the latest advancements in weight loss treatments as developers race to create the next blockbuster solution. Stay informed about the cutting-edge options available.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
OCTOBER 8, 2024
John Maraganore, the former CEO of Alnylam Pharmaceuticals turned biotech elder statesman and venture capitalist, is launching a new startup that he hopes can expand upon his previous company’s success. His new venture, City Therapeutics, launched Tuesday with $135 million from ARCH Venture Partners, Fidelity, Invus, Rock Springs Capital, Regeneron Ventures, and others, he told STAT exclusively.
pharmaphorum
OCTOBER 8, 2024
Stay updated on the latest insights from EASD 2024 with a comprehensive breakdown of key themes, topics, and influencers. Learn more about the essential information you need to know.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
OCTOBER 8, 2024
Collaboration is essential for the future of healthcare, and events play a pivotal role in fostering it. Learn how collaboration can drive innovation in healthcare through impactful events.
STAT
OCTOBER 8, 2024
A trade group representing large compounding pharmacies has sued the U.S. Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list. The Outsourcing Facilities Association argued that a shortage of the drug, known as tirzepatide, actually still exists and the agency action was a coup for the company that came at the expense of the public.
pharmaphorum
OCTOBER 8, 2024
Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings in early 2025.The stock rocketed 362% after the announcement, taking Scholar Rock's market cap above $2.7 billion, as analysts started to talk about a blockbuster sales opportunity for the selective myostatin inhibitor.
STAT
OCTOBER 8, 2024
Amid ongoing scrutiny of pharmacy benefit managers, the U.S. Supreme Court has asked the solicitor general to weigh in on an Oklahoma law that seeks to regulate the retail networks created by these controversial middlemen in the pharmaceutical supply chain. The law, which was enacted in 2019, was designed to ensure that pharmacy benefit managers maintain access to a large number of pharmacies and do not steer patients to favored outlets, among other things.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Express Pharma
OCTOBER 8, 2024
Biomedical engineers at the University of Strathclyde are involved in two new healthcare technology hubs. The MAINSTREAM project focuses on using technology to manufacture human stem cells outside the body. It aims to overcome barriers to the use of mesenchymal stem cells to aid tissue regeneration for broken bones and in chemotherapy, where they can help regenerate healthy bone marrow.
STAT
OCTOBER 8, 2024
As Biogen aims to grow sales of postpartum depression drug Zurzuvae, it’s turning to well-funded telehealth company Talkiatry to boost awareness of and care for the often overlooked condition. Under the deal, Talkiatry, which recently raised $130 million and employs over 350 psychiatrists, created a new landing page on its website with information about postpartum depression.
Express Pharma
OCTOBER 8, 2024
Zydus Wellness has extended its legacy brand Complan into adult nutrition with the launch of VieMax. The new nutrition drink is scientifically designed with protein, prebiotics, and probiotics to support muscle mass, gut wellness, and overall immunity among adults. Tarun Arora, CEO of Zydus Wellness, said, “VieMax is a perfect complement to our existing portfolio at Complan.
STAT
OCTOBER 8, 2024
LONDON — Two pioneers behind machine learning — a technology that is already transforming society in ways big and small and that carries profound ethical questions — won the Nobel Prize in physics on Tuesday. The award went to John Hopfield, 91, of Princeton University and Geoffrey Hinton, 76, of the University of Toronto, “for foundational discoveries and inventions that enable machine learning with artificial neural networks,” the Nobel committee announced.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Express Pharma
OCTOBER 8, 2024
Eli Lilly ‘s Ebglyss (lebrikizumab) has recently received approval in the US, adding a new competitor to the atopic dermatitis (AD) market alongside therapies like tralokinumab and dupilumab. Although there are current treatment options ranging from topical therapies to systemic treatments there is a significant unmet need remains for safer and more effective long-term AD therapies, which may further be addressed by this new approval in the US, says GlobalData.
STAT
OCTOBER 8, 2024
Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and middle-income countries, marking the second time in two years the company is taking such steps. But as before, the move was met with criticism over certain details. The latest effort involves tripling the annual supply of the drug, a long-acting medication known as cabotegravir, in hopes of making more than 2 million doses available during 2025 and 2026.
Express Pharma
OCTOBER 8, 2024
Eppendorf has introduced the CellXpert CS220, the first CO2 incubator shaker with an integrated 180°C sterilisation routine. This new product is designed to support mammalian cell culture projects, particularly in areas such as the expression of complex recombinant proteins, production of viral vectors, and bioreactor starter cultures. Maria Mattern, responsible for innovations in Eppendorf’s shaker and CO2 incubator portfolio, commented on the development, “Our new CellXpert CS220 was developed
STAT
OCTOBER 8, 2024
Good morning! We’ve got a lot of news to share today, including another dispatch from Drew on the Nobels. Let’s get to it. Physics Nobel goes to pioneers of machine learning John Hopfield of Princeton University and Geoffrey Hinton of the University of Toronto, two researchers behind the development of machine learning, won the Nobel Prize in physics on Tuesday.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Express Pharma
OCTOBER 8, 2024
OneSource Specialty Pharma, a newly formed contract development and manufacturing organisation (CDMO), has emerged from the merger of three CDMO businesses within the Strides Group. The group, which has a 30-year history in manufacturing and quality, has launched its new brand identity with a focus on customer service and specialisation in biologics, drug-device combinations, and soft gelatin capsules.
STAT
OCTOBER 8, 2024
NEW YORK — More than a dozen states and the District of Columbia filed lawsuits against TikTok on Tuesday, alleging the popular short-form video app is harming youth mental health by designing its platform to be addictive to kids. The lawsuits stem from a national investigation into TikTok, which was launched in March 2022 by a bipartisan coalition of attorneys general from many states, including California, Kentucky, and New Jersey.
Express Pharma
OCTOBER 8, 2024
Amneal Pharmaceuticals, a U.S.-based global pharmaceutical company, has announced plans to build two new manufacturing facilities in Ahmedabad, India. This expansion marks the company’s continued growth in the country, where it has operated since 2008. The investment, which is projected to be between USD$150 million and $200 million, will take place over the next four to five years and will focus on peptide synthesis and advanced sterile fill-finish manufacturing.
STAT
OCTOBER 8, 2024
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascots are bounding about the grounds in search of creatures to annoy. As for us, we are as busy as ever hunting and gathering items of interest. We trust you have your own hectic agendas. So join us as we hoist the ever-present cup of stimulation — our choice today is coconut rum — and attack the fast-growing to-do list.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Pharmacist
OCTOBER 8, 2024
Government is committed to making ‘better use of the skills of pharmacy teams’ and to ‘build on pharmacies presence at the heart of communities’, Stephen Kinnock minister of state for care, has told pharmacy contractors. But in a recorded message to delegates attending the Sigma conference at Heathrow on Sunday, Mr Kinnock said that he […] The post Finding sustainable funding solution is ‘matter of urgency’ for government appeared first on The Pharmacist.
STAT
OCTOBER 8, 2024
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Otsuka and Amalgam partner on Alzheimer’s care tech Precision health company Otsuka — which, you may remember, decided to price its depression digital therapeutic lower to make it more accessible even if it’ll lose money on it — is now partnering w
Drug Patent Watch
OCTOBER 8, 2024
A recent study published in Drug Discovery Today highlights the potential of artificial intelligence (AI) in revolutionizing drug discovery and development processes[1]. The research, conducted by a team from the University of Cambridge and AstraZeneca, explores how AI can be leveraged to enhance various aspects of pharmaceutical research, from target identification to clinical trials.
STAT
OCTOBER 8, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning. Lots of great stories from my colleagues today so we’ll jump straight into it.
pharmaphorum
OCTOBER 8, 2024
Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS in draft guidance
World Pharma News
OCTOBER 8, 2024
Novo Nordisk today announced a new global initiative to prevent obesity in children. The Childhood Obesity Prevention Initiative aims to accelerate the prevention of childhood obesity in disadvantaged urban communities globally. Together with a coalition of partners such as city governments, academic institutions and non-profit organisations, the initiative will support six cities in designing, implementing and evaluating tailored solutions focused on physical activity and healthy eating.
pharmaphorum
OCTOBER 8, 2024
AstraZeneca and Owkin form alliance to develop an AI tool to pre-screen breast cancer patients for BRCA mutations from digital pathology slides.
Pharmaceutical Technology
OCTOBER 8, 2024
The Phase III trials will evaluate survodutide in metabolic dysfunction-associated steatohepatitis (MASH), fibrosis and cirrhosis.
pharmaphorum
OCTOBER 8, 2024
Astellas adds a gene therapy for frontotemporal dementia to its pipeline, via a $2.2bn+ option deal with UK biotech AviadoBio.
PioneerRx
OCTOBER 8, 2024
The devastation caused by natural disasters is often unprecedented, and preparedness is key to mitigating their impact. With climate experts noting an increase.
Expert insights. Personalized for you.
363 
Let's personalize your content